Ideal Cardiovascular Health Associations With Biomarkers and Subclinical Disease and Impact on Incidence of Cardiovascular Disease in the Framingham Offspring Study Epidemiology

was associated with higher circulating concentrations of natriuretic peptides (N-terminal pro-atrial natriuretic peptide and B-type natriuretic peptide) and lower blood concentrations of plasminogen activator inhibitor-1, aldosterone, C-reactive protein, D-dimer, fibrinogen, homocysteine, and growth differentiation factor-15 levels ( P <0.001 for all), as well as lower odds of subclinical disease (odds ratio, 0.74 per 1-unit increase in CVH score; 95% confidence interval, 0.68–0.80). The incidence of CVD (267 events over 16 years) was inversely associated with the CVH score in age- and sex-adjusted models (hazard ratio, 0.77 per 1-unit increase in CVH score; 95% confidence interval, 0.70–0.86), which was slightly attenuated upon adjustment for biomarkers and subclinical disease (hazard ratio, 0.87; 95% confidence interval, 0.78–0.97). Conclusion —In our prospective community-based study, the inverse association between an ideal cardiovascular health score and CVD incidence was partly attributable to its favorable impact on CVD biomarker levels and subclinical disease. ( Circulation . 2014;130:1676-1683.)

[1]  V. Vaccarino,et al.  Life’s Simple 7 and Risk of Incident Stroke: The Reasons for Geographic and Racial Differences in Stroke Study , 2013, Stroke.

[2]  J. J. Rivera,et al.  Low-risk lifestyle, coronary calcium, cardiovascular events, and mortality: results from MESA. , 2013, American journal of epidemiology.

[3]  J. Boucher,et al.  Prevalence of the American Heart Association's “Ideal Cardiovascular Health” Metrics in a Rural, Cross‐sectional, Community‐Based Study: The Heart of New Ulm Project , 2013, Journal of the American Heart Association.

[4]  J. Viikari,et al.  Ideal Cardiovascular Health in Adolescence: Effect of Lifestyle Intervention and Association With Vascular Intima-Media Thickness and Elasticity (The Special Turku Coronary Risk Factor Intervention Project for Children [STRIP] Study) , 2013, Circulation.

[5]  D. Lloyd‐Jones,et al.  Adding a life-course perspective to cardiovascular-risk communication , 2013, Nature Reviews Cardiology.

[6]  Lihui Zhao,et al.  Lifetime risk and years lived free of total cardiovascular disease. , 2012, JAMA.

[7]  D. Levy,et al.  Prognostic Utility of Novel Biomarkers of Cardiovascular Stress: The Framingham Heart Study , 2012, Circulation.

[8]  Kuibao Li,et al.  Prevalence of Ideal Cardiovascular Health and Its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City , 2012, Circulation. Cardiovascular quality and outcomes.

[9]  R. Sacco,et al.  Ideal Cardiovascular Health Predicts Lower Risks of Myocardial Infarction, Stroke, and Vascular Death Across Whites, Blacks, and Hispanics: The Northern Manhattan Study , 2012, Circulation.

[10]  T. Lehtimäki,et al.  Ideal Cardiovascular Health in Childhood and Cardiometabolic Outcomes in Adulthood: The Cardiovascular Risk in Young Finns Study , 2012, Circulation.

[11]  F. Hu,et al.  Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. , 2012, JAMA.

[12]  Yuling Hong,et al.  Ideal Cardiovascular Health and Mortality From All Causes and Diseases of the Circulatory System Among Adults in the United States , 2012, Circulation.

[13]  Martha L. Daviglus,et al.  Status of Cardiovascular Health in US Adults: Prevalence Estimates From the National Health and Nutrition Examination Surveys (NHANES) 2003–2008 , 2012, Circulation.

[14]  A. Folsom,et al.  Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence. , 2011, Journal of the American College of Cardiology.

[15]  S. Reis,et al.  Low Prevalence of “Ideal Cardiovascular Health” in a Community-Based Population: The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study , 2011, Circulation.

[16]  Michael J. Pencina,et al.  Statistical methods for assessment of added usefulness of new biomarkers , 2010, Clinical chemistry and laboratory medicine.

[17]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[18]  J. Murabito,et al.  Burden and Prognostic Importance of Subclinical Cardiovascular Disease in Overweight and Obese Individuals , 2007, Circulation.

[19]  J. Murabito,et al.  Prevalence and Prognostic Impact of Subclinical Cardiovascular Disease in Individuals With the Metabolic Syndrome and Diabetes , 2007, Diabetes.

[20]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[21]  D. Levy,et al.  Impact of Obesity on Plasma Natriuretic Peptide Levels , 2004, Circulation.

[22]  D. Maclean,et al.  The global burden of cardiovascular diseases. , 1999, The Canadian journal of cardiology.

[23]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[24]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .